Genentech controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile2 entries
2009
Use of company lobbying language in congressional statements
News reporting said that language prepared by Genentech lobbyists appeared in statements by members of Congress during the U.S. health-care reform debate, raising concerns about the transparency of corporate influence.
1999
UCSF Protropin patent dispute
The University of California, San Francisco sued Genentech over alleged use of university-developed technology connected with recombinant human growth hormone and Protropin. Genentech disputed the claim, and the matter was resolved through a $200 million settlement.